BiotechTube
Meso Scale Discovery

Meso Scale Discovery

Rockville, United States· Est.
mesoscale.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Meso Scale Discovery (MSD) is a privately-held US-based company providing advanced immunoassay systems and services for the research and biomarker discovery markets. Founded in 1995, the company has commercialized its proprietary MULTI-ARRAY and electrochemiluminescence (ECL) technology platform, offering instruments and assay kits known for high sensitivity and multiplexing capability. MSD operates primarily in the diagnostics tools and services sector, generating revenue from the sale of its instruments, consumables, and custom assay development services to academic, pharmaceutical, and biotechnology research clients globally.

Immunology/InflammationNeurobiology/NeurodegenerationOncology & CancerCardiovascularToxicologyMetabolicReproductive Biology

Technology Platform

Proprietary electrochemiluminescence (ECL) detection combined with MULTI-ARRAY carbon electrode plates. Enables highly sensitive, broad dynamic range, multiplex immunoassays for protein and biomarker analysis.

Opportunities

The growing demand for multiplex biomarker analysis in drug discovery and translational research represents a core opportunity.
The transition of validated biomarkers from research into clinical diagnostics presents a significant long-term market expansion potential for its ECL technology platform.

Risk Factors

Intense competition from larger, diversified life science tools companies and potential technological disruption from emerging ultra-high-plex proteomics platforms.
Remaining confined to the Research Use Only market limits addressable market size compared to clinical diagnostics.

Competitive Landscape

MSD competes in the high-performance multiplex immunoassay space against companies like Luminex (xMAP technology) and divisions of large conglomerates like Thermo Fisher Scientific. It differentiates based on the sensitivity, dynamic range, and low sample volume requirements of its electrochemiluminescence platform.

More companies in Diagnostics & Precision Medicine →More companies in United States →